本発表は英語のみのお知らせとなります

The GHIT Fund is establishing a Drug Discovery Screening Platform to facilitate the screening of compound libraries for identification of novel compounds for malaria, tuberculosis, and neglected tropical diseases. The goal is to leverage the active screening programs of established Product Development Partnerships (PDPs) and the relevant compound libraries from Japanese companies or academic institutions.

The expectation is that the Japanese entity will provide its relevant compound libraries to their PDP partner, who will then conduct screening with support from their established screening organization network. The GHIT Fund will reimburse for screening project costs.

Interested partnerships are required to submit the Contact Form by email to RFPResponse@ghitfund.org
no later than 5:00pm JST on May 13th, 2013 (please use email subject: Potential Screening Platform). Questions specific to this Screening Platform can only be answered with the submission of this information.

A GHIT Fund staff member will contact interested parties to discuss the funding process. If partnerships have not been identified, GHIT Fund staff are available to help facilitate communication with prospective parties. Interested organizations that are not able to form a partnership by the above deadline will be encouraged to participate in future funding calls.